Fennec Announces Results of Annual Meeting
(firmenpresse) - RESEARCH TRIANGLE PARK, NORTH CAROLINA -- (Marketwired) -- 06/28/17 -- Fennec Pharmaceuticals Inc. (TSX: FRX)(OTCQB: FENCF) today announced that the nominees listed in the management proxy circular dated May 19, 2017 (the "Circular") for the Annual General and Special Meeting of Shareholders were elected as directors of the Company at the Annual General and Special Meeting of Shareholders held in New York, New York on June 27, 2017. Detailed results of the vote for the election of directors are set out below:
Shareholders voted 97.33% in favour of appointing Haskell & White LLP as auditors and authorizing the directors to fix the auditor remuneration, 99.98% in favour of approving the Company's Shareholder Rights Plan, and 99.96% in favour of the compensation paid to the Company's named executive officers.
Contacts:
Fennec Pharmaceuticals Inc.
Rosty Raykov
Chief Executive Officer
(919) 636-5144
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 28.06.2017 - 16:59 Uhr
Sprache: Deutsch
News-ID 550316
Anzahl Zeichen: 0
contact information:
Town:
RESEARCH TRIANGLE PARK, NORTH CAROLINA
Kategorie:
Alternative
Diese Pressemitteilung wurde bisher 218 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Fennec Announces Results of Annual Meeting"
steht unter der journalistisch-redaktionellen Verantwortung von
Fennec Pharmaceuticals Inc. (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
